Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The therapeutic potential of targeting regulated non-apoptotic cell death
Kamyar Hadian, Brent R. Stockwell
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 9, pp. 723-742
Closed Access | Times Cited: 162

Showing 1-25 of 162 citing articles:

The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions
Guang Lei, Li Zhuang, Boyi Gan
Cancer Cell (2024) Vol. 42, Iss. 4, pp. 513-534
Open Access | Times Cited: 106
Targeting immunogenic cell stress and death for cancer therapy
Lorenzo Galluzzi, Emma Guilbaud, Darby Schmidt, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 6, pp. 445-460
Open Access | Times Cited: 76
Roles of Oxidative Stress in Synaptic Dysfunction and Neuronal Cell Death in Alzheimer’s Disease
Germán Plascencia‐Villa, George Perry
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1628-1628
Open Access | Times Cited: 55
Multi drug resistance in Colorectal Cancer- approaches to overcome, advancements and future success
Sumel Ashique, Mithun Bhowmick, Radheshyam Pal, et al.
Advances in Cancer Biology - Metastasis (2024) Vol. 10, pp. 100114-100114
Open Access | Times Cited: 42
Glutathione‐Scavenging Celastrol‐Cu Nanoparticles Induce Self‐Amplified Cuproptosis for Augmented Cancer Immunotherapy
Sheng Lü, Yifan Li, Yingjie Yu
Advanced Materials (2024) Vol. 36, Iss. 35
Closed Access | Times Cited: 41
Bioactive Layered Double Hydroxides for Synergistic Sonodynamic/Cuproptosis Anticancer Therapy with Elicitation of the Immune Response
Wei Tang, Jie Wu, Li Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 15, pp. 10495-10508
Closed Access | Times Cited: 37
Metabolic cell death in cancer: ferroptosis, cuproptosis, disulfidptosis, and beyond
Chao Mao, Min Wang, Li Zhuang, et al.
Protein & Cell (2024) Vol. 15, Iss. 9, pp. 642-660
Open Access | Times Cited: 36
A Vacancy‐Engineering Ferroelectric Nanomedicine for Cuproptosis/Apoptosis Co‐Activated Immunotherapy
Yaqian Du, Xudong Zhao, Fei He, et al.
Advanced Materials (2024) Vol. 36, Iss. 30
Closed Access | Times Cited: 35
A Copper/Ferrous‐Engineering Redox Homeostasis Disruptor for Cuproptosis/Ferroptosis Co‐Activated Nanocatalytic Therapy in Liver Cancer
Xiaoling Zhang, Jiuxin Zhu, Sihao Wang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 37
Closed Access | Times Cited: 27
Gasdermin and MLKL necrotic cell death effectors: Signaling and diseases
Kate E. Lawlor, James M. Murphy, James E. Vince
Immunity (2024) Vol. 57, Iss. 3, pp. 429-445
Closed Access | Times Cited: 19
Chemical Design of Magnetic Nanomaterials for Imaging and Ferroptosis-Based Cancer Therapy
Wei Xu, Guoqiang Guan, Renye Yue, et al.
Chemical Reviews (2025)
Closed Access | Times Cited: 4
BRD4-targeted photodegradation nanoplatform for light activatable melanoma therapy
Shiman Lu, Zhaoqing Shi, Chendi Ding, et al.
Biomaterials (2025) Vol. 317, pp. 123101-123101
Closed Access | Times Cited: 2
Farnesoid X receptor activation by bile acids suppresses lipid peroxidation and ferroptosis
Juliane Tschuck, Lea Theilacker, Ina Rothenaigner, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 34
Cuproptosis and cuproptosis-related genes: Emerging potential therapeutic targets in breast cancer
Xiangdong Liu, Bo Luo, Xinhong Wu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 6, pp. 189013-189013
Closed Access | Times Cited: 27
Biomaterials Elicit Pyroptosis Enhancing Cancer Immunotherapy
Meng‐Jie Zhang, Yuanyuan Wang, Lin‐Lin Han, et al.
Advanced Functional Materials (2023) Vol. 34, Iss. 7
Closed Access | Times Cited: 24
Molecular landmarks of tumor disulfidptosis across cancer types to promote disulfidptosis-target therapy
Deze Zhao, Yu Meng, Yating Dian, et al.
Redox Biology (2023) Vol. 68, pp. 102966-102966
Open Access | Times Cited: 23
Regulated cell death‐amplified sonodynamic anti‐tumor immune nanotherapeutics
Liqiang Zhou, Yangmengfan Chen, Dong Xie, et al.
BMEMat (2024)
Open Access | Times Cited: 14
Stimulation of tumoricidal immunity via bacteriotherapy inhibits glioblastoma relapse
Yulin Zhang, Kaiyan Xi, Zhipeng Fu, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Cell death pathways: molecular mechanisms and therapeutic targets for cancer
Shaohui Wang, Sa Guo, Jing Guo, et al.
MedComm (2024) Vol. 5, Iss. 9
Open Access | Times Cited: 12
Targeting anoikis resistance as a strategy for cancer therapy
Yumin Wang, Sihang Cheng, Joshua S. Fleishman, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101099-101099
Closed Access | Times Cited: 11
SBFI26 induces triple‐negative breast cancer cells ferroptosis via lipid peroxidation
Gang He, Yiyuan Zhang, Yanjiao Feng, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 7
Open Access | Times Cited: 9
Disulfidptosis: A new type of cell death
Fei Xiao, Huili Li, Bei Yang, et al.
APOPTOSIS (2024)
Open Access | Times Cited: 9
Suppression of ferroptosis by vitamin A or radical-trapping antioxidants is essential for neuronal development
Juliane Tschuck, Vidya Padmanabhan Nair, Ana Galhoz, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Utilizing Extracellular Vesicles for Eliminating ‘Unwanted Molecules’: Harnessing Nature’s Structures in Modern Therapeutic Strategies
Monika Kisielewska, Katarzyna Rakoczy, Izabela Skowron, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 948-948
Open Access | Times Cited: 8
Therapeutic strategies of targeting non-apoptotic regulated cell death (RCD) with small-molecule compounds in cancer
Xin Jin, Wenke Jin, L. Tong, et al.
Acta Pharmaceutica Sinica B (2024) Vol. 14, Iss. 7, pp. 2815-2853
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top